In older adults, cannabinoid-based medicines increase adverse events compared with placebo.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 34487442.
- Also identified by DOI 10.7326/ACPJ202109210-103.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Velayudhan L, McGoohan K, Bhattacharyya S. <b>Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: a systematic review and meta-analysis.</b> PLoS Med. 2021;18:e1003524. 33780450.
Medical subject headings
- Cannabinoids